VSee Health, Inc. (VSEEW) Financial Ratios
5 years of historical data (2020–2024) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
↓
N/A
—
5yr avg: -199.9%
30Y Low42%·High62%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
VSEEW Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
VSee Health, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $544726 | $509630 | — | — | — | — |
| Enterprise Value | $10M | $10M | — | — | — | — |
| P/E Ratio → | -0.01 | — | — | — | — | — |
| P/S Ratio | 0.05 | 0.05 | — | — | — | — |
| P/B Ratio | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
VSEEW EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.93 | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
VSEEW Profitability
Margins and return-on-capital ratios measuring operating efficiency
VSee Health, Inc. earns an operating margin of -596.4%. Operating margins have compressed from -56.4% to -596.4% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 68.9% | 68.9% | 66.9% | 75.8% | 80.7% | 80.3% |
| Operating Margin | -596.4% | -596.4% | -25.2% | -56.4% | 3.4% | 5.9% |
| Net Profit Margin | -553.7% | -553.7% | -59.0% | -50.8% | 6.5% | 3.8% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | — | — | — | -703.6% | 61.9% | 42.1% |
| ROA | -554.2% | -554.2% | -200.3% | -142.6% | 20.4% | 9.5% |
| ROIC | -1500.1% | -1500.1% | — | -625.8% | 68.9% | — |
| ROCE | -6327.9% | -6327.9% | — | -780.1% | 32.8% | 65.8% |
VSEEW Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $9M ($10M total debt minus $326115 cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 0.22 |
| Debt / EBITDA | — | — | — | — | — | — |
| Net Debt / Equity | — | — | — | — | -0.38 | -1.05 |
| Net Debt / EBITDA | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | -0.81 |
| Interest Coverage | -293.91 | -293.91 | -0.68 | -112.81 | — | — |
VSEEW Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.16x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.29x to 0.16x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.16 | 0.16 | 0.19 | 0.29 | 0.77 | 0.70 |
| Quick Ratio | 0.16 | 0.16 | 0.19 | 0.29 | 0.77 | 0.70 |
| Cash Ratio | 0.02 | 0.02 | 0.03 | 0.09 | 0.34 | 0.37 |
| Asset Turnover | — | 0.52 | 7.03 | 2.44 | 3.79 | 2.50 |
| Inventory Turnover | — | — | — | — | — | — |
| Days Sales Outstanding | — | 78.74 | 39.27 | 22.29 | 14.23 | 35.35 |
VSEEW Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
VSee Health, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $10M | $4M | $13M | $15M | $15M |
Peer Comparison
Compare VSEEW with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 VSEEWYou | $544726 | -0.0 | — | — | 68.9% | -596.4% | — | -1500.1% | — |
 TDOC | $1B | -6.4 | 15.6 | 4.6 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 AMWL | $133M | -1.3 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
 OPRX | $120M | 23.9 | 6.3 | 6.4 | 67.3% | 10.7% | 4.2% | 7.1% | 0.3 |
 TALK | $869M | 129.8 | 138.1 | — | 43.0% | 1.4% | 6.6% | 3.9% | — |
 HIMS | $7B | 55.4 | 46.5 | 98.7 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 |
 DOCS | $5B | 23.4 | 21.1 | 19.6 | 90.2% | 39.9% | 22.5% | 20.0% | 0.1 |
 PHVS | $2B | -10.3 | — | — | — | — | -41.2% | — | — |
 WELL | $150B | 154.4 | 66.9 | 52.8 | 39.2% | 3.3% | 2.5% | 0.5% | 8.6 |
 NVCR | $2B | -14.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 VEEV | $27B | 30.6 | 28.1 | 19.1 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
| Healthcare Median | — | 22.2 | 14.4 | 18.6 | 64.0% | -5.1% | -33.9% | -11.1% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 5 years · Updated daily
See VSEEW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VSEEW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VSEEW vs TDOC
Side-by-side business, growth, and profitability comparison vs Teladoc Health, Inc..
Start ComparisonVSEEW — Frequently Asked Questions
Quick answers to the most common questions about buying VSEEW stock.
What is VSee Health, Inc.'s P/E ratio?
VSee Health, Inc.'s current P/E ratio is -0.0x. This places it at the 50th percentile of its historical range.
Is VSEEW stock overvalued?
Based on historical data, VSee Health, Inc. is trading at a P/E of -0.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are VSee Health, Inc.'s profit margins?
VSee Health, Inc. has 68.9% gross margin and -596.4% operating margin.